Folk J, (1977) lysine cross-link and the catalytic role of transglutaminases,

Kim S.-Y, (1997) Novel transglutaminase inhibitors reduce the cornified cell envelope formation,

Kim S.-Y, (2002) Transglutaminases in disease,

Lee J, (2004) Transglutaminase 2 induces NF-B activation via a novel pathway in BV-2 microglia, in press

Mirza A, (1997) A role for tissue transglutaminase in hepatic injury and fibrogenesis and its regulation by NF-B,

Sohn J, (2003) A New Anti-Inflammatory Approach in Allergic Conjunctivitis,

Chae J, (2004) Association for Research in Vision and Ophthalmology,

Suh G, (2004) A novel peptide with anti-transglutaminase activity decreases LPS-induced lung inflammation in mice,

Miele L, (1988) Novel anti-inflammatory peptides from the region of highest similarity between uteroglobulin and lipocortin1,

Miele L, (1990) A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity,

Miele L, (1993) Transglutaminase-catalyzed incorporation of polyamines into phospholipase A2,

Esposito C, (20031813-1820) Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease,

D'Argenio G, (1995) Transglutaminases in Crohn's disease,

Choi Y, (2000) Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2,

Taggart C, (2002) Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IB- degradation without affecting phosphorylation or ubiquitination,

Marsh M, (1992) a molecular and immunobiologic approach to the spectrum of gluten sensitivity,

Dieterich W, (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease,

Bruce S, (1985) demonstration of activity enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease,

Nilsen E, (1998) Gluten induces an intestinal cytokine response strongly dominated by interferon- in patients with celiac disease,

Kim S, (2002) Interferon- induces transglutaminase 2 expression in rat small intestinal cells Implications for the pathogenesis of celiac disease,

Schroff G, (1981) Transglutaminase as a marker for subsets of murine macrophages,

Harris L, (1984) Increased transglutaminase activity in elicited and activated macrophages relationship to production of superoxide anion,

Murtaugh M, (1983) Induction of tissue transglutaminase in mouse peritoneal macrophages,

Esposito C, (20031813-20) Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease,

Alvarez R, -Amyloid precursor epitopes in muscle fibers of inclusion body myositis,

Wei Zhang, (1997) Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid -peptide,

Choi Y, (2004) Increase in transglutaminase 2 in idiopathic inflammatory myopathies,

and Collin P, (1997) Diseases associated with dermatitis herpetiformis,

Bao F, (1999) One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease associated transglutaminase autoantibodies,

Sanchez D, (2000) Occurrence of IgA and IgG Autoantibodies to Calreticulin in Coeliac Disease and Various Autoimmune Diseases,

Weinberg J, (1991) Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis,

Orth T, (1997) Actin is a target antigen of anti-neutrophil cytoplasmic antibodies,

Nemes Z, (1997) Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis,

Blackwell C, (1995) Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica with or without insulin-dependent diabetes mellitus,

Boulila A, (1996) Characterization of autoantibody in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematous patients,

(1975) A review with observations on the histochemical and immunochemical localization of the enzyme, Keratin cross-linking and epidermal transglutaminase

and Franco L, (1996) Core histones are glutaminyl substrates for tissue transglutaminase,

Ando Y, (1992) The presence of autoantibody to lipocortin-I in autoimmune-prone MRL mice,

Ando Y, (1991) Calcium-induced intracellular cross-linking of lipocortin I by tissue transglutaminase in A431 cells Augmentation by membrane phospholipids,

Chuang L, (1998) Transglutaminase-induced cross-linking between subdomain 2 of G-actin and the 636-642 lysine-rich loop of myosin subfragment 1,

Cardona A, (1995) Evidence for an antigen-driven selection process in human auto-antibodies against acetylcholine receptor,

Bergamini C, (1995) Transglutaminase-catalyzed polymerization of troponin in vitro,

(1994) Natural Autoantibodies are Involved in the Haemolytic Anaemia of NZB Mice,

Farrace M, (1999) Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis,

FEBS Lett, (1986) Ca2+-dependent inactivation of acetylcholine receptors by an endogenous transglutaminase,

Ehnis T, (1998) Identification of the autoantigen of coeliac disease,

Hudson B, (2000) The -5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency,

Folk J, (1987) Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen,

Chimanovitch I, (2000) Bullous pemphigoid of childhood autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood,

Borza D, (2000) Identification of multiple cryptic epitopes on the NC1 domain of the 3,

Diab B, (1999) Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis,

Wajgt A, (1983) CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis Evidence of the intrathecal production of antibodies,

Brain transglutaminase, (1982) in vitro crosslinking of human neurofilament proteins into insoluble polymers,

Aeschlimann D, (2000) Protein crosslinking in assembly and remodeling of extracellular matrices the role of transglutaminases,

phase II study, (1996) in treatment of hypertrophic scars,

Griffin M, (1979) Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induce by paraquat,

Johnson T, (1997) The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis,

Muesch A, (1990) A novel pathway for secretary proteins? Trends,

Mosher D, (1991) Assembly of fibronectin into extracellular matrix,

A, (1997) Thrombin cleavage-independent deposition of fibrinogen in extracellular matrices,

Aeschlimann D, (1995) Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage identification of osteonectin as a major glutaminyl substrate,

Sorensen E, (1994) Localization of transglutaminase-reactive glutamine residues in bovine osteopontin,

Mosher D, (1984) Cross-linking of fibronectin to collagenous proteins,

Folk J, (1987) Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen,

Kleman J, (1995) Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells,

Hopfner B, (1996) Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts Anchoring fibrils are a target for tissue transglutaminase,

Sane D, (1988) Vitronectin is a substrate for transglutaminases,

Hand D, (2000) Stabilization of collagen-tailed acetylcholinesterase in muscle cells through extracellular anchorage by transglutaminase-catalyzed cross-linking,

Ito S, (1994) Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed,

Ritchie H, (2000) Cross-linking of plasminogen activator inhibitor 2 and 2-antiplasmin to fibrin,

Kojima S, (1993) Requirement for transglutaminase in the activation of latent transforming growth factor- in bovine endothelial cells,

Rosenthal A, (2000) Participation of transglutaminase in the activation of latent transforming growth factor-1 in aging articular cartilage,

Zhu J, (1999) Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis,

El Alaoui S, (2001) Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis,

Zhu J, TNF modulates expression of the tissue transglutaminase gene in liver cells,